(© Shakil - stock.adobe.com)
Some Organs Age Years Faster Than Others, New AI Research Shows
In A Nutshell
- AI models trained on microscope images can estimate the biological age of 40 tissue types across 29 organs, predicting age within about 4.88 years on average.
- Aging doesn’t happen at the same pace everywhere in the body; some organs show clear signs of faster wear than others in the same person.
- A blood-based version of the tool detected accelerated organ aging in people already diagnosed with conditions like Alzheimer’s disease, stroke, and Crohn’s disease.
- The study cannot yet confirm whether these aging signals show up before disease develops, since all tissue samples came from people who had already died.
Your heart might be aging faster than your lungs. Your kidneys could be decades older than your skin. Scientists may now be capable of estimating such discrepancies with no more than a blood sample, at least in a research setting.
Researchers have developed AI tools that estimate the biological age of 40 tissue types across 29 organs, then use blood samples to predict those age gaps. Published in Nature Medicine, the study used tissue images and paired blood gene expression data from 983 individuals to train AI models that read the microscopic fingerprints of aging. Models were validated in cohorts spanning eight diseases, including Alzheimer’s disease, stroke, and Crohn’s disease, and blood data alone was enough to detect accelerated organ aging in people who already had these conditions, though whether similar signals appear before disease develops remains an open question.
Most people think of aging as a single, uniform process that moves at the same pace across the body over time. This research makes clear that aging is more like a patchwork quilt, with some organs fraying faster than others in ways researchers hope could eventually help detect trouble earlier.
AI Models Pinpointed Organ Age to Within Five Years
To build these tools, researchers drew on a public resource called the Genotype-Tissue Expression project, or GTEx, pulling more than 25,000 high-resolution microscope slide images covering 40 tissue types from 983 individuals ranging in age from 20 to 70, with tissue collected quickly after death and reviewed by pathologists.
Researchers trained AI vision models to recognize each tissue type’s microscopic structure, then built what they called “tissue clocks,” tools estimating biological age from tissue’s appearance under a microscope. On average, clocks predicted age within about 4.88 years. A predicted age higher than actual age signaled accelerated aging; lower predicted age showed comparatively slower biological aging.
Aging Tissue Shrinks and Loses Blood Vessels
Using AI tools that connect images to text descriptions, researchers identified features that increased across multiple organs with age: tissue shrinkage, loss of tiny blood vessels, and buildup of scar-like material, while features tied to active cell growth declined. Some changes were specific to certain tissues: fat increasingly infiltrated skeletal muscle, blood vessels thinned in the uterus, and peripheral nerves showed shrinkage.
Tissues that looked biologically older also tended to have shorter protective DNA caps called telomeres, a well-established marker of cellular aging, and that relationship was stronger for tissue-clock age than for chronological age alone.
Kidney Failure Tied to Faster Aging Beyond the Kidneys
Kidney failure showed one of the strongest links to accelerated aging, but not in the kidneys themselves; the effect showed up hardest in fatty tissue, the spleen, a small hormone-regulating gland at the base of the brain, and leg nerve tissue. Unexplained seizures were associated with accelerated aging in the cerebellum, the brain region involved in coordination, and high blood pressure in men was linked to faster prostate aging. Well-established connections were confirmed too: respiratory disease with lung aging, diabetes with pancreatic aging, heart disease with fatty tissue aging.
Blood Tests Detected Aging Signals Tied to Disease
Collecting tissue from a living person is invasive; blood draws are not. Linking blood gene data to tissue aging patterns from GTEx samples let researchers build predictors estimating organ-specific biological age from blood alone.
To validate this, researchers used blood from 577 healthy people and 628 with one of seven chronic diseases: lupus, Crohn’s disease, diabetes, cystic fibrosis, ulcerative colitis, vasculitis, and Alzheimer’s disease, plus stroke patients, since a stroke happens suddenly rather than building over years.
Stroke patients showed the most pronounced aging signal in the brain, matching the affected tissue, plus elevated kidney and liver signals authors suggested could reflect treatment effects. Crohn’s disease tracked with faster aging from esophagus to colon. Vasculitis, involving inflammation of blood vessels, showed elevated aging in the kidney, liver, and heart. In Alzheimer’s disease, the brain alone showed a significantly elevated signal, while cystic fibrosis, primarily a lung disease, showed elevated brain aging signals authors linked to possible reduced oxygen reaching the brain.
Blood tests moderately to strongly told sick people apart from healthy ones, a result that held for people already diagnosed, not for spotting who might get sick later.
Study Cannot Yet Confirm Disease Prediction
For all its scope, this study has real limits. Tissue samples came from people already deceased, so researchers worked with a snapshot rather than tracking individuals over time. That design identifies patterns but cannot establish cause and effect, and cannot answer whether an elevated organ-aging signal in blood appears before disease strikes, the harder and more clinically useful question. There was also a dataset imbalance, roughly two men for every woman, which researchers acknowledged affected some tissue clocks, particularly for female reproductive tissues.
Still, a tool reading the biological ages of multiple organs from one blood sample, even in a research context, is no small feat. If future studies confirm elevated tissue-aging signals precede disease onset, this could become a meaningful way to catch organ decline before it becomes irreversible.
Disclaimer: This article is based on findings published in a peer-reviewed scientific journal and is intended for general informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Readers with health concerns should consult a qualified healthcare provider.
Paper Notes
Limitations
The study relied on postmortem tissue samples from individuals who had died from accidents, suicide, or natural causes, which limits the ability to draw conclusions about how and when disease processes begin. Because this study looked at one moment in time rather than following the same people for years, researchers could identify associations between aging signals and disease but could not establish cause and effect or determine whether elevated aging signals appear before disease onset. The GTEx cohort had approximately twice as many male donors as female donors, which affected the performance of some tissue clocks. Additionally, variable time between death and tissue collection could have introduced some biological noise into the tissue samples, though researchers adjusted for this factor where possible. Finally, blood-based tissue age predictions were validated in people who already had disease, not in people who later developed it, meaning the tool’s predictive value for future disease remains an open question.
Funding and Disclosures
Funding for the research group of André F. Rendeiro was provided by Angelini Ventures S.p.A. and the European Research Council under the European Union’s Horizon Europe research and innovation program (grant 101220825). GTEx project support came from the Common Fund of the Office of the Director of the National Institutes of Health and multiple NIH institutes. Additional funding came from the German Cancer Aid, the Helmholtz Association, the German Center for Lung Research, the Research Foundation of Flanders, the National Health and Medical Research Council of Australia, Cure Cancer Australia, the FWF Austrian Science Fund, the LEO Foundation, the Germany Research Society, the Vienna Science and Technology Fund, and the Ludwig Boltzmann Clinical Research Group ATTRACT. Ernesto Abila, Iva Buljan, Yimin Zheng, and André F. Rendeiro declared competing financial interests in the form of a patent related to this work. Laurens J. De Sadeleer reported travel grants, speaker’s fees, and research collaborations with pharmaceutical companies. Adelheid Wöhrer received honoraria for lectures. All other authors declared no competing interests.
Publication Details
Paper title: Histological aging signatures for monitoring tissue-specific aging and disease Authors: Ernesto Abila, Iva Buljan, Yimin Zheng, and colleagues (full author list includes more than 25 contributors from institutions across Austria, Germany, Belgium, and Australia) Journal: Nature Medicine Published: August 14, 2026 DOI: https://doi.org/10.1038/s41591-026-04566-5







